Scarica l'app Stockscreener
6.93
2.67%
-0.19
Dopo l'orario di chiusura:
7.01
0.08
+1.15%
Unicycive Therapeutics Inc Borsa (UNCY) Ultime notizie
Aug Movers: Should you avoid Unicycive Therapeutics Inc stock right now2026 Sentiment & Risk Managed Investment Entry Signals - baoquankhu1.vn
HC Wainwright Boosts Earnings Outlook for Unicycive Therapeutics - National Today
HC Wainwright Issues Positive Estimate for UNCY Earnings - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Reach Out - ACCESS Newswire
Guggenheim Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Cuts Target Price to $40 - Moomoo
Unicycive Therapeutics (UNCY) Target Price Lowered by Guggenheim | UNCY Stock News - GuruFocus
Guggenheim Has Lowered Expectations for Unicycive Therapeutics (NASDAQ:UNCY) Stock Price - marketbeat.com
Noble Financial Has Positive Forecast for UNCY Q1 Earnings - marketbeat.com
UNCY Stock Price, Quote & Chart | UNICYCIVE THERAPEUTICS INC (NASDAQ:UNCY) - ChartMill
UNCY SEC FilingsUnicycive Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
H.C. Wainwright Sticks to Their Buy Rating for Unicycive Therapeutics (UNCY) - theglobeandmail.com
Noble Financial Brokers Boost Earnings Estimates for UNCY - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Noble Financial Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Maintains Target Price $60 - Moomoo
Unicycive Therapeutics | 10-K: FY2025 Annual Report - Moomoo
Unicycive Therapeutics, Inc. (UNCY) Reports FY2025 Earnings - AlphaStreet
USA Rare Earth, Inc. (USAR) Reports Q4 Earnings - AlphaStreet
Unicycive Therapeutics Reports 2025 Financial Results; OLC NDA Under FDA Review with Potential Approval in June 2026 - Minichart
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update - National Today
Unicycive Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Unicycive Therapeutics (NASDAQ:UNCY) Releases Quarterly Earnings Results, Misses Estimates By $0.36 EPS - MarketBeat
Unicycive (UNCY) narrows 2025 loss, FDA accepts kidney drug NDA resubmission - Stock Titan
Unicycive Therapeutics : March 2026 Corporate Presentation - MarketScreener
Unicycive Therapeutics 10-K: Net loss $26.6M, EPS $(1.67) - TradingView
Unicycive (NASDAQ: UNCY) advances OLC NDA toward June 2026 PDUFA as UNI-494 is paused - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Published on: 2026-03-28 07:58:35 - baoquankhu1.vn
Published on: 2026-03-27 21:20:10 - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Unicycive Therapeutics (UNCY) Stock Analysis Report | Financials & Insights - Benzinga Japan
Portfolio Recap: Is Unicycive Therapeutics Inc stock risky to hold nowEarnings Summary Report & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Unicycive Therapeutics (UNCY) to Release Quarterly Earnings on Monday - marketbeat.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Investors to Connect - ACCESS Newswire
Pullback Watch: Is Unicycive Therapeutics Inc a potential multi baggerQuarterly Earnings Report & Risk Managed Trade Strategies - baoquankhu1.vn
Stop Loss: Why is Unicycive Therapeutics Inc stock going down2026 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
If You Invested $1,000 in Unicycive Therapeutics Inc (UNCY) - Stock Titan
Unicycive Therapeutics Company Profile & Introduction - Moomoo
UNCY Technical Analysis & Stock Price Forecast - Intellectia AI
Important Notice to Long-Term Shareholders of ASP Isotopes - GlobeNewswire
Important Notice to Long-Term Shareholders of ASP Isotopes Inc. (NASDAQ: ASPI); Integer Holdings Corp. (NYSE: ITGR): Soleno Therapeutics, Inc. (NASDAQ: SLNO); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Reach Out - ACCESS Newswire
Notice to Long-Term Shareholders of ASP Isotopes Inc. - GlobeNewswire
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Connect - ACCESS Newswire
Unicycive Therapeutics (NASDAQ:UNCY) Shares Down 0.4%Here's Why - MarketBeat
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of Integer Holdings Corp. (NYSE: ITGR): Molina Healthcare, Inc. (NYSE: MOH); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Important Notice to Long-Term Shareholders of Boston - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Investors to Inquire about Securities Investigation - ACCESS Newswire
Unicycive Therapeutics (UNCY) price target decreased by 12.88% to 47.43 - MSN
Aug Setups: Is Unicycive Therapeutics Inc on track to beat earningsTrade Volume Report & Fast Gain Stock Tips - baoquankhu1.vn
Kuehn Law Encourages Investors of Unicycive Therapeutics, Inc. to Contact Law Firm - TMX Newsfile
Important Notice to Long-Term Shareholders of Corcept - GlobeNewswire
UNCY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Piper Sandler Remains a Buy on Unicycive Therapeutics (UNCY) - The Globe and Mail
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):